We’re excited about the value that our testing has brought to patients in the US, and are looking forward to bringing SmartGut and SmartJane to Canada.
SAN FRANCISCO (PRWEB) January 26, 2018
uBiome, the leader in microbial genomics, announced today that Canadian residents can now request uBiome clinical testing from healthcare providers. These tests include SmartGut™, the world’s first sequencing-based clinical microbiome test, and SmartJane™, the world’s first women’s health test to genotype all clinically relevant strains of human papillomavirus (HPV) in addition to screening for sexually transmitted infections (STIs) and imbalances in vaginal flora.
Dr. Jessica Richman, uBiome co-founder and CEO, says: “uBiome created SmartGut and SmartJane to empower more patients to take an active role in their health and wellness in close partnership with their healthcare providers. We’re excited about the value that our testing has brought to patients in the US, and are looking forward to to bringing SmartGut and SmartJane to Canada.”
SmartGut and SmartJane are medical tests that allow patients to easily test their gut and vaginal microbiomes, respectively, in the privacy and comfort of home. Samples are returned to and processed in uBiome’s CLIA-licensed and CAP-accredited laboratory in San Francisco, California, using a patented process called precision sequencing™.
The results outline the beneficial and pathogenic microorganisms associated with specific infections and common conditions related to the sampled microbiome. For SmartGut, this includes gut symptoms like bloating, constipation, diarrhea and other symptoms of irritable bowel syndrome and inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s Disease, whether a diagnosis has been made or not. For SmartJane, this includes both high- and low-risk strains of HPV, common STIs like chlamydia, gonorrhea, syphilis and mycoplasma genitalium and changes in bacterial populations, like lactobacillus, which can be responsible for pelvic inflammatory disease and bacterial vaginosis, among others.
Results are made available to both the patient and requesting healthcare provider via uBIome’s secure patient portal to help foster important discussions about treatment and wellness, but they are not intended to diagnose conditions such as cancer and do not replace the need for other clinical tests, including the Pap smear for women.
For more information on SmartGut or SmartJane and how to request a kit, please visit http://www.ubiome.com.
Founded in 2012, uBiome is the world’s leading microbial genomics company with a mission to explore important research questions about the microbiome and develop reliable, accurate products and services, focused on the microbiome. uBiome is funded by Y Combinator, Andreessen Horowitz, 8VC and other leading investors. uBiome’s mission is to transform the science of the microbiome into useful products and services that improve people’s lives.